Phase I tolerability/safety of sunitinib in combination with capecitabine in patients (pts) with advanced solid tumors

被引：0
|
作者：
Verschraegen, C. [1 ]
Sweeney, C. [2 ]
Chiorean, G. [2 ]
Lee, F. C. [1 ]
Jones, S. [3 ]
Tye, L. [4 ]
Bello, A. [5 ]
Chao, R. [4 ]
Burris, H., III
机构：
[1] Univ New Mexico, Canc Res & Treatment Ctr, Albuquerque, NM 87131 USA
[2] Indiana Univ, Indiana Univ Canc Ctr, Indianapolis, IN USA
[3] Sarah Cannon Res Inst, Nashville, TN USA
[4] Pfizer Inc, La Jolla, CA USA
[5] Pfizer Inc, New York, NY USA
来源：
EJC SUPPLEMENTS | 2007年 / 5卷 / 04期
关键词：
D O I：
10.1016/S1359-6349(07)70513-X
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
714
引用
收藏
页码：111 / 111
页数：1
相关论文
共 50 条
  • [31] A PHASE I DOSE ESCALATION STUDY OF SUNITINIB (SU) IN COMBINATION WITH PEMETREXED (PEM) IN PATIENTS (PTS) WITH ADVANCED SOLID MALIGNANCIES
    Chow, L. Q. M.
    Jonker, D. J.
    Laurie, S. A.
    Call, J. A.
    Diab, S. G.
    McWilliam, M.
    Wang, E.
    Chao, R.
    Eckhardt, S. G.
    Camidge, D. R.
    ANNALS OF ONCOLOGY, 2008, 19 : 159 - 159
  • [32] Sunitinib (SU) in combination with pemetrexed (P) in patients (pts) with advanced solid malignancies: A phase I dose escalation study
    Chow, L. Q.
    Jonker, D. J.
    Laurie, S. A.
    Call, J. A.
    Diab, S. G.
    Goss, G.
    McWilliam, M.
    Wang, E.
    Chao, R.
    Eckhardt, S. G.
    Camidge, D. R.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [33] A phase I study of the safety, tolerability and pharmacokinetics of pazopanib (P) in combination with gemcitabine (G) for advanced solid tumors
    Richly, H.
    Rubin, S. D.
    Madi, A.
    Jeffels, M.
    Nokay, B.
    Gibson, D.
    Weller, S.
    Scheulen, M. E.
    Plummer, R.
    EJC SUPPLEMENTS, 2010, 8 (07): : 25 - 25
  • [34] Phase I study of elisidepsin (E) in combination with carboplatin (C) in patients (pts) with advanced solid tumors
    Faivre, S. J.
    Ropert, S.
    Coronado, C.
    Alcantara, J.
    De Miguel, B.
    Soto, A.
    Szyldergemajn, S. A.
    Loussilaho, G.
    Mir, O.
    Goldwasser, F.
    Raymond, E.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [35] A phase I study of E7820 in combination with Cetuximab in patients (pts) with advanced solid tumors
    El-Khoueiry, A. B.
    Iqbal, S.
    Feit, K.
    Lenz, H. J.
    Okereke, C.
    Krivelevich, I.
    Goldberg, T.
    Conti, P.
    Rossignol, D.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [36] Phase I study of PM00104 in combination with carboplatin in patients (pts) with advanced solid tumors
    Calvo, Emiliano
    Gil, Marta
    Coronado, Cinthya
    Valer, Anna
    Duran, Ignacio
    Hidalgo, Manuel
    Pardo, Beatriz
    Calles, Antonio
    Garcia, Margarita
    Morelli, Pia
    Kahatt, Carmen
    Prados, Raquel
    Fernandez, Carlos
    Salazar, Ramon
    CANCER RESEARCH, 2012, 72
  • [37] A phase I study of the safety and pharmacokinetics of the combination of pertuzumab (rhuMab 2C4) and capecitabine in patients with advanced solid tumors
    Albanell, Joan
    Montagut, Clara
    Jones, Eileen T.
    Pronk, Linda
    Mellado, Begona
    Beech, Janette
    Gascon, Pere
    Zugmaier, Gerhard
    Brewster, Michael
    Saunders, Mark P.
    Valle, Juan W.
    CLINICAL CANCER RESEARCH, 2008, 14 (09) : 2726 - 2731
  • [38] Phase I study of capecitabine (C) in combination with cisplatin (DDP) and irinotecan (IRI) in patients (pts) with advanced solid malignancies
    Sayar, H.
    Verschraegen, C. F.
    Smith, H.
    Rabinowitz, I.
    Lee, F. C.
    Shen, Z.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [39] The Safety and Tolerability of Vorinostat in Combination with Lapatinib in Advanced Solid Tumors
    Chumsri, S.
    Tait, N. S.
    Medeiros, M. M.
    Bauer, K. S.
    Betts, K-M T.
    Lewis, J. C.
    Bao, T.
    Feigenberg, S. J.
    Kesmodei, S. B.
    Stearns, V.
    Edelman, M. J.
    Sausville, E. A.
    Tkaczuk, K. H. R.
    CANCER RESEARCH, 2011, 71
  • [40] PHASE I SAFETY AND TOLERABILITY OF ONCE DAILY ORAL AFATINIB (A) (BIBW 2992) IN COMBINATION WITH GEMCITABINE (G) IN PATIENTS (PTS) WITH ADVANCED SOLID TUMOURS
    Zanetta, S.
    Bennouna, J.
    Isambert, N.
    De Mont-Serrat, H.
    Tschoepe, I.
    Squiban, P.
    Delord, J.
    ANNALS OF ONCOLOGY, 2012, 23 : 165 - 165
12345